Morgan David L, Borys Douglas J, Stanford Rhandi, Kjar Dean, Tobleman William
Central Texas Poison Center, the Department of Emergency Medicine, Scott and White Memorial Hospital, Texas A&M System Health Science Center, Temple, TX 76508, USA.
South Med J. 2007 Feb;100(2):152-6. doi: 10.1097/01.smj.0000253596.39121.19.
The clinical features of bites from Texas coral snakes (Micrurus tener) have not been well studied. Our goal was to review the largest number of victims of Texas coral snakebites to determine their characteristics, effects, treatment, and outcome.
Retrospective case series of Micrurus tener exposures reported to the Texas Poison Center Network from 2000 to 2004.
Eighty-two patients were included in the analysis. Most (57.3%) were 18 to 49-year-old men. Almost 90% had local swelling, pain, erythema, or paresthesias. Only 7.3% had systemic effects, and none of these were severe. Over half received coral snake antivenin, and 15.9% were given opioids for pain. No patient died and no patient required mechanical ventilation due to hypoventilation from the snakebite.
There were more local findings and less severe systemic effects than previously reported. Antivenin is not needed for most of these patients, and opioids may be administered safely.
德州珊瑚蛇(Micrurus tener)咬伤的临床特征尚未得到充分研究。我们的目标是回顾数量最多的德州珊瑚蛇咬伤受害者,以确定其特征、影响、治疗方法及结果。
对2000年至2004年向德州中毒控制中心网络报告的Micrurus tener暴露情况进行回顾性病例系列研究。
82例患者纳入分析。大多数(57.3%)为18至49岁男性。近90%有局部肿胀、疼痛、红斑或感觉异常。只有7.3%有全身影响,且均不严重。超过半数接受了珊瑚蛇抗蛇毒血清治疗,15.9%因疼痛使用了阿片类药物。无患者死亡,也无患者因蛇咬伤导致的通气不足而需要机械通气。
与之前报道相比,局部表现更多,全身影响不严重。大多数此类患者不需要抗蛇毒血清,阿片类药物可安全使用。